Cargando…

High expression of DEK predicts poor prognosis of gastric adenocarcinoma

BACKGROUND: DEK, as an oncoprotein, plays an important role in cancer development and progression. This study aimed to investigate the clinicopathological significance of DEK overexpression in patients with gastric cancer. MATERIALS AND METHODS: The expression of DEK protein was evaluated by immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piao, Junjie, Shang, Yongjun, Liu, Shuangping, Piao, Yingshi, Cui, Xuelian, Li, Yuzi, Lin, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994479/ https://www.ncbi.nlm.nih.gov/pubmed/24650035 http://dx.doi.org/10.1186/1746-1596-9-67

Ejemplares similares

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

High expression of ezrin predicts poor prognosis in uterine cervical cancer
por: Kong, Jienan, et al.
Publicado: (2013)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer
por: Lin, Lijuan, et al.
Publicado: (2014)

High Expression of Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Chen, Liyan, et al.
Publicado: (2014)

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma
por: Yi, Huochun, et al.
Publicado: (2019)

G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo
por: Zhu, Kun, et al.
Publicado: (2022)

Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
por: Wang, Xue, et al.
Publicado: (2022)

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis
por: Zhao, Ting, et al.
Publicado: (2019)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle
por: Albahde, Mugahed Abdullah Hasan, et al.
Publicado: (2020)

Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis
por: Li, Nan, et al.
Publicado: (2019)

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
por: Piao, Junjie, et al.
Publicado: (2016)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

LMX1B-associated gankyrin expression predicts poor prognosis in glioma patients
por: Guo, Xu, et al.
Publicado: (2020)

LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma
por: Ehara, Takehito, et al.
Publicado: (2021)

High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
por: Zhang, Hailing, et al.
Publicado: (2022)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer
por: Dong, Bing, et al.
Publicado: (2019)

DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
por: Yang, Mai-Qing, et al.
Publicado: (2021)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Clinical implications of high NQO1 expression in breast cancers
por: Yang, Yang, et al.
Publicado: (2014)

DEK‐targeting aptamer DTA‐64 attenuates bronchial EMT‐mediated airway remodelling by suppressing TGF‐β1/Smad, MAPK and PI3K signalling pathway in asthma
por: Song, Yilan, et al.
Publicado: (2020)

High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma
por: Song, Junnian, et al.
Publicado: (2021)

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
por: Li, Pulin, et al.
Publicado: (2022)

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)

The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis
por: Zhu, Guang, et al.
Publicado: (2021)

Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients
por: Zheng, Yan, et al.
Publicado: (2014)

Decreased Expression of the GATA3 Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma
por: Keshari, Rajiv Prasad, et al.
Publicado: (2014)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017)

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Cui, Ming, et al.
Publicado: (2020)

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7gpo9d81b2p7dnqtrhbterd93p